Filing Details
- Accession Number:
- 0001181431-14-007432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-18 18:04:16
- Reporting Period:
- 2014-02-13
- Filing Date:
- 2014-02-18
- Accepted Time:
- 2014-02-18 18:04:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1527573 | H. Eric Siegel | Experimental Station Route 141 And Henry Clay Rd Wilmington DE 19880 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-13 | 27 | $17.79 | 1,214 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 3,245 | $16.66 | 4,459 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 4,445 | $14.72 | 8,904 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 2,778 | $14.00 | 11,682 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 1,112 | $14.72 | 12,794 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 1,389 | $14.00 | 14,183 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 10,390 | $17.79 | 24,573 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 4,802 | $16.66 | 29,375 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-13 | 26,667 | $18.32 | 56,042 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-13 | 54,855 | $66.67 | 1,187 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-02-13 | 1,187 | $66.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 27 | $0.00 | 27 | $17.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 3,245 | $0.00 | 3,245 | $16.66 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 4,445 | $0.00 | 4,445 | $14.72 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 2,778 | $0.00 | 2,778 | $14.00 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 1,112 | $0.00 | 1,112 | $14.72 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 1,389 | $0.00 | 1,389 | $14.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 10,390 | $0.00 | 10,390 | $17.79 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-02-13 | 4,802 | $0.00 | 4,802 | $16.66 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-13 | 26,667 | $0.00 | 26,667 | $18.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,385 | 2019-01-18 | No | 4 | M | Direct | |
| 0 | 2017-10-28 | No | 4 | M | Direct | |
| 0 | 2018-01-24 | No | 4 | M | Direct | |
| 0 | 2018-08-08 | No | 4 | M | Direct | |
| 0 | 2018-01-24 | No | 4 | M | Direct | |
| 4,167 | 2018-08-08 | No | 4 | M | Direct | |
| 22,616 | 2019-01-18 | No | 4 | M | Direct | |
| 0 | 2017-10-28 | No | 4 | M | Direct | |
| 45,454 | 2020-02-08 | No | 4 | M | Direct |
Footnotes
- Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning October 29, 2010, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning August 9, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Represents weighted average sale price. Actual sales prices ranged from $65.52-$67.26.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Billionaire Hedge Funds
